Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.
about
Is surgery still the optimal treatment for stage I non-small cell lung cancer?The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial LesionsStereotactic body radiotherapy in lung cancer: an updateAre three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC PatientsComplications from Stereotactic Body Radiotherapy for Lung CancerEmergence of stereotactic body radiation therapy and its impact on current and future clinical practiceStereotactic Body Radiotherapy in the Management of Oligometastatic DiseaseSpecific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review.Equivalence of cell survival data for radiation dose and thermal dose in ablative treatments: analysis applied to essential tremor thalamotomy by focussed ultrasound and gamma knife.The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapyAnniversary Paper: the role of medical physicists in developing stereotactic radiosurgery.Normal tissue toxicity after small field hypofractionated stereotactic body radiation.Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancerLung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results.Four-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer: a comparative planning study.Endovascular coils as lung tumour markers in real-time tumour tracking stereotactic radiotherapy: preliminary results.Retrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs)Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology GroupA comprehensive dosimetric study on switching from a Type-B to a Type-C dose algorithm for modern lung SBRTA pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapyCyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.Hypofractionated radiotherapy for lung tumors with online cone beam CT guidance and active breathing controlNo clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects.CyberKnife for hilar lung tumors: report of clinical response and toxicity.American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer.The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancerFeasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates.Role of radiation therapy in the management of renal cell cancerStereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review.Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer.Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases.Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancerInterventional pulmonology approaches in the diagnosis and treatment of early stage non small cell lung cancerFeasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments.Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study.Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
P2860
Q26749371-5D49CD42-2E0C-4FEE-8E52-0B1B9BCF20ACQ26770254-1F2372DB-34EA-4B13-BB19-88007FECE623Q26781806-4E63CBEA-CFC3-4C45-B05C-B6F0D67842E8Q26823670-B5B1B90A-332A-4F96-8270-AE2B17423D0CQ26851601-9EA185BC-47AE-4F44-B52F-E485DB14330CQ26995851-673DD601-CBA1-4839-9047-BA4D8665A117Q27015651-B507B79D-25CF-45E4-B8F2-31BFF70F0691Q28071733-59F4C403-1F1E-4E24-85ED-41BB534E1CEDQ30241812-25EE5890-21E7-44AB-B1A4-E583A5C16DD3Q30275112-F0E35062-0477-43E5-89FD-6DB656B535DEQ30443893-C35EC9B9-7F11-4B96-8F09-9EABF55520ADQ30447048-F3496D87-15D5-441E-BB65-F84EF821F9BBQ30484881-E402C904-3632-4F68-9ED9-DE59D72C234FQ30857091-4C833D6C-AFDD-47A2-B0E5-CBFFCF11E287Q33257945-99B15B13-7854-42E6-A952-4C17743B192EQ33315026-D1493380-F272-47A2-8FC0-A6F0A5E5B6E3Q33326998-5BA24F20-1361-46C3-9A39-4A986C621FEFQ33571109-4DE55706-64E8-4712-A15A-831DDB274F79Q33582628-DB5DABBD-1D1B-4289-8A0F-CE2F27956062Q33644800-740F77AC-B34C-4552-A4DC-DC116B07FCA2Q33664774-9E7BC6EA-33D8-4521-8CEB-01BAAD91583EQ33698367-B776188E-CC7E-4E8A-BBD4-75D6FB309407Q33729123-052E3289-1236-4E91-94A8-DA7CC346E177Q33758565-8FF96CB7-5E33-486D-8F1C-AB94DEDCAC67Q33805678-BE48CBBD-D822-4717-A956-9A766DCE26A6Q34304095-1AB4C79B-B3F5-419C-A11C-DD0B8A3836DAQ34331400-5FEF1C58-3171-4483-A3B8-306511CEA525Q34337294-B2C13906-97AA-42FA-B246-4DBD48E88693Q34366525-F50E6420-0170-46DB-B4DB-C06488A43993Q34366580-EC278B14-172A-41B2-8130-6AE8C3B65A24Q34499545-751C8398-4E6E-4379-B2C0-C99308D4CD8EQ34657336-07D11612-0CA2-4EB7-916D-FE785F2DD460Q34667302-8001D3D9-A483-4CB2-B806-E276E972530AQ35033807-788D005D-8D9A-42CD-9F83-C1A937981B43Q35053368-9D208FC2-67C5-45D9-8477-DB42F7DBD66DQ35111775-CC9C415F-32E4-4114-83E2-D644114EE8D7Q35200670-3F672E18-CB82-4E33-B7FD-14D83344312AQ35232033-927544F0-7D27-4D2B-A8E7-35860ECCD29FQ35599955-7D03C5EB-C47C-412C-BAAC-6EF4CE8B3551Q35734103-14156198-E8F4-4151-8872-845253D4657E
P2860
Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Extracranial stereotactic radi ...... I non-small cell lung cancer.
@en
Extracranial stereotactic radi ...... I non-small cell lung cancer.
@nl
type
label
Extracranial stereotactic radi ...... I non-small cell lung cancer.
@en
Extracranial stereotactic radi ...... I non-small cell lung cancer.
@nl
prefLabel
Extracranial stereotactic radi ...... I non-small cell lung cancer.
@en
Extracranial stereotactic radi ...... I non-small cell lung cancer.
@nl
P2093
P356
P1433
P1476
Extracranial stereotactic radi ...... I non-small cell lung cancer.
@en
P2093
Colleen DesRosiers
Laura Likes
Lech Papiez
Mark Williams
Robert Timmerman
Ronald McGarry
Stephanie Frost
P304
P356
10.1378/CHEST.124.5.1946
P407
P577
2003-11-01T00:00:00Z